tenofovir (anhydrous)
A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens is replaced by a [(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(isopropyloxycarbonyloxymethyl) ester (disoproxil ester) prodrug is used as the fumaric acid salt in combination therapy for the treatment of HIV infection.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
Chemical structure
| Molecular formula | C9H14N5O4P |
|---|---|
| Charge | 0 |
| Average mass | 287.216 Da |
| Monoisotopic mass | 287.07834 Da |
| Source | ChEBI |
| InChIKey | SGOIRFVFHAKUTI-ZCFIWIBFSA-N |
C[C@H](Cn1cnc2c(N)ncnc21)OCP(=O)(O)O
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
Also called
- tenofovir
- ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid
- (R)-PMPA
- anh. tenofovir
- anhydrous tenofovir
- tenofovir (anh.)
Cross-references
- cas:147127-20-6
- hmdb:HMDB0014445
- lincs.smallmolecule:LSM-5340
- reaxys:7415378
Drug registries
Patents and articles
Activity roles
- antiviral drug
CHEBI:36044 - HIV-1 reverse transcriptase inhibitor
CHEBI:53756
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:63625 |
tenofovir (anhydrous) | antibioticmech:chebi-9199045bb4 |
2026-08-30 |
Mechanism summary
- Mode of action
- VIRAL_POLYMERASE_INHIBITION microbial target
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories